HEADER TRANSCRIPTION 03-MAY-18 6GG8 TITLE MINERALOCORTICOID RECEPTOR IN COMPLEX WITH (S)-13 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MR,NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 2; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: NCOA-1,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74, COMPND 10 PROTEIN HIN-2,RIP160,RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID COMPND 11 RECEPTOR COACTIVATOR 1,SRC-1; COMPND 12 EC: 2.3.1.48; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C2, MCR, MLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: NCOA1, BHLHE74, SRC1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS MINERALOCORTICOID RECEPTOR, NUCLEAR HORMONE RECEPTOR, STEROID KEYWDS 2 RECEPTOR, LIGAND COMPLEX, PEPTIDE COMPLEX, SIGNALING PROTEIN, KEYWDS 3 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR K.EDMAN,A.AAGAARD,S.TANGEFJORD REVDAT 4 17-JAN-24 6GG8 1 REMARK REVDAT 3 24-APR-19 6GG8 1 JRNL REVDAT 2 06-FEB-19 6GG8 1 JRNL REVDAT 1 09-JAN-19 6GG8 0 JRNL AUTH K.L.GRANBERG,Z.Q.YUAN,B.LINDMARK,K.EDMAN,J.KAJANUS,A.HOGNER, JRNL AUTH 2 M.MALMGREN,G.O'MAHONY,A.NORDQVIST,J.LINDBERG,S.TANGEFJORD, JRNL AUTH 3 M.KOSSENJANS,C.LOFBERG,J.BRANALT,D.LIU,N.SELMI,G.NIKITIDIS, JRNL AUTH 4 P.NORDBERG,A.HAYEN,A.AAGAARD,E.HANSSON,M.HERMANSSON, JRNL AUTH 5 I.IVARSSON,R.JANSSON-LOFMARK,U.KARLSSON,U.JOHANSSON, JRNL AUTH 6 L.WILLIAM-OLSSON,J.HARTLEIB-GESCHWINDNER,K.BAMBERG JRNL TITL IDENTIFICATION OF MINERALOCORTICOID RECEPTOR MODULATORS WITH JRNL TITL 2 LOW IMPACT ON ELECTROLYTE HOMEOSTASIS BUT MAINTAINED ORGAN JRNL TITL 3 PROTECTION. JRNL REF J.MED.CHEM. V. 62 1385 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30596500 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01523 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 28137 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1401 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.38 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2863 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3411 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2726 REMARK 3 BIN R VALUE (WORKING SET) : 0.3390 REMARK 3 BIN FREE R VALUE : 0.3869 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.79 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 137 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2071 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.92 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.71690 REMARK 3 B22 (A**2) : 1.23890 REMARK 3 B33 (A**2) : -1.95570 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.250 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.138 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.122 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.131 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.118 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2209 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2995 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 786 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 55 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 315 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2209 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 276 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2804 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.68 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.01 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -2.1189 11.4504 -13.6256 REMARK 3 T TENSOR REMARK 3 T11: -0.0775 T22: -0.0827 REMARK 3 T33: 0.0064 T12: -0.0188 REMARK 3 T13: 0.0026 T23: -0.0126 REMARK 3 L TENSOR REMARK 3 L11: 0.8279 L22: 0.7429 REMARK 3 L33: 0.9736 L12: -0.0410 REMARK 3 L13: -0.0181 L23: 0.0890 REMARK 3 S TENSOR REMARK 3 S11: -0.0200 S12: 0.0533 S13: -0.0186 REMARK 3 S21: -0.0062 S22: 0.0097 S23: 0.0292 REMARK 3 S31: 0.0393 S32: -0.0136 S33: 0.0102 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GG8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200009900. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.57 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28185 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 36.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.84400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4UDA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9M (NH4)2SO4, 0.1 M CHES PH9.5, 10% REMARK 280 (V/V) OF CONDITION C8 OF THE MORPHEUS SCREEN (MOLECULAR REMARK 280 DIMENSION), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.32700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.37750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.97650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.37750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.32700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.97650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 713 REMARK 465 HIS A 714 REMARK 465 ASN A 715 REMARK 465 HIS A 716 REMARK 465 ASN A 717 REMARK 465 HIS A 718 REMARK 465 ASN A 719 REMARK 465 HIS A 720 REMARK 465 ASN A 721 REMARK 465 HIS A 722 REMARK 465 ASN A 723 REMARK 465 HIS A 724 REMARK 465 ASN A 725 REMARK 465 GLY A 726 REMARK 465 GLY A 727 REMARK 465 GLU A 728 REMARK 465 ASN A 729 REMARK 465 LEU A 730 REMARK 465 TYR A 731 REMARK 465 PHE A 732 REMARK 465 GLN A 733 REMARK 465 GLY A 734 REMARK 465 THR A 735 REMARK 465 PRO A 736 REMARK 465 PRO A 911 REMARK 465 ASN A 912 REMARK 465 ASN A 913 REMARK 465 SER A 914 REMARK 465 GLY A 915 REMARK 465 GLN A 916 REMARK 465 GLY A 985 REMARK 465 GLY A 986 REMARK 465 SER A 987 REMARK 465 LEU A 988 REMARK 465 VAL A 989 REMARK 465 PRO A 990 REMARK 465 ARG A 991 REMARK 465 GLY A 992 REMARK 465 SER A 993 REMARK 465 GLY A 994 REMARK 465 GLY A 995 REMARK 465 GLY A 996 REMARK 465 SER A 997 REMARK 465 GLY A 998 REMARK 465 GLY A 999 REMARK 465 SER A 1000 REMARK 465 GLY A 1001 REMARK 465 GLY A 1002 REMARK 465 PRO A 1003 REMARK 465 GLN A 1004 REMARK 465 ALA A 1005 REMARK 465 GLN A 1006 REMARK 465 GLN A 1007 REMARK 465 LYS A 1008 REMARK 465 SER A 1009 REMARK 465 LEU A 1010 REMARK 465 LEU A 1011 REMARK 465 GLN A 1012 REMARK 465 GLN A 1013 REMARK 465 LEU A 1014 REMARK 465 LEU A 1015 REMARK 465 THR A 1016 REMARK 465 GLU A 1017 REMARK 465 PRO B 1427 REMARK 465 GLN B 1428 REMARK 465 ALA B 1429 REMARK 465 GLN B 1430 REMARK 465 GLN B 1431 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 948 61.56 -116.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EY8 A 1102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6GEV RELATED DB: PDB REMARK 900 PDB ENTRY FROM THE SAME PAPER DBREF 6GG8 A 735 984 UNP P08235 MCR_HUMAN 735 984 DBREF 6GG8 B 1427 1441 UNP Q15788 NCOA1_HUMAN 1427 1441 SEQADV 6GG8 MET A 713 UNP P08235 INITIATING METHIONINE SEQADV 6GG8 HIS A 714 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ASN A 715 UNP P08235 EXPRESSION TAG SEQADV 6GG8 HIS A 716 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ASN A 717 UNP P08235 EXPRESSION TAG SEQADV 6GG8 HIS A 718 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ASN A 719 UNP P08235 EXPRESSION TAG SEQADV 6GG8 HIS A 720 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ASN A 721 UNP P08235 EXPRESSION TAG SEQADV 6GG8 HIS A 722 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ASN A 723 UNP P08235 EXPRESSION TAG SEQADV 6GG8 HIS A 724 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ASN A 725 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 726 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 727 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLU A 728 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ASN A 729 UNP P08235 EXPRESSION TAG SEQADV 6GG8 LEU A 730 UNP P08235 EXPRESSION TAG SEQADV 6GG8 TYR A 731 UNP P08235 EXPRESSION TAG SEQADV 6GG8 PHE A 732 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLN A 733 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 734 UNP P08235 EXPRESSION TAG SEQADV 6GG8 SER A 808 UNP P08235 CYS 808 CONFLICT SEQADV 6GG8 SER A 910 UNP P08235 CYS 910 CONFLICT SEQADV 6GG8 GLY A 985 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 986 UNP P08235 EXPRESSION TAG SEQADV 6GG8 SER A 987 UNP P08235 EXPRESSION TAG SEQADV 6GG8 LEU A 988 UNP P08235 EXPRESSION TAG SEQADV 6GG8 VAL A 989 UNP P08235 EXPRESSION TAG SEQADV 6GG8 PRO A 990 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ARG A 991 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 992 UNP P08235 EXPRESSION TAG SEQADV 6GG8 SER A 993 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 994 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 995 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 996 UNP P08235 EXPRESSION TAG SEQADV 6GG8 SER A 997 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 998 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 999 UNP P08235 EXPRESSION TAG SEQADV 6GG8 SER A 1000 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 1001 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLY A 1002 UNP P08235 EXPRESSION TAG SEQADV 6GG8 PRO A 1003 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLN A 1004 UNP P08235 EXPRESSION TAG SEQADV 6GG8 ALA A 1005 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLN A 1006 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLN A 1007 UNP P08235 EXPRESSION TAG SEQADV 6GG8 LYS A 1008 UNP P08235 EXPRESSION TAG SEQADV 6GG8 SER A 1009 UNP P08235 EXPRESSION TAG SEQADV 6GG8 LEU A 1010 UNP P08235 EXPRESSION TAG SEQADV 6GG8 LEU A 1011 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLN A 1012 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLN A 1013 UNP P08235 EXPRESSION TAG SEQADV 6GG8 LEU A 1014 UNP P08235 EXPRESSION TAG SEQADV 6GG8 LEU A 1015 UNP P08235 EXPRESSION TAG SEQADV 6GG8 THR A 1016 UNP P08235 EXPRESSION TAG SEQADV 6GG8 GLU A 1017 UNP P08235 EXPRESSION TAG SEQRES 1 A 305 MET HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN SEQRES 2 A 305 GLY GLY GLU ASN LEU TYR PHE GLN GLY THR PRO SER PRO SEQRES 3 A 305 VAL MET VAL LEU GLU ASN ILE GLU PRO GLU ILE VAL TYR SEQRES 4 A 305 ALA GLY TYR ASP SER SER LYS PRO ASP THR ALA GLU ASN SEQRES 5 A 305 LEU LEU SER THR LEU ASN ARG LEU ALA GLY LYS GLN MET SEQRES 6 A 305 ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU PRO GLY PHE SEQRES 7 A 305 LYS ASN LEU PRO LEU GLU ASP GLN ILE THR LEU ILE GLN SEQRES 8 A 305 TYR SER TRP MET SER LEU SER SER PHE ALA LEU SER TRP SEQRES 9 A 305 ARG SER TYR LYS HIS THR ASN SER GLN PHE LEU TYR PHE SEQRES 10 A 305 ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS MET HIS GLN SEQRES 11 A 305 SER ALA MET TYR GLU LEU CYS GLN GLY MET HIS GLN ILE SEQRES 12 A 305 SER LEU GLN PHE VAL ARG LEU GLN LEU THR PHE GLU GLU SEQRES 13 A 305 TYR THR ILE MET LYS VAL LEU LEU LEU LEU SER THR ILE SEQRES 14 A 305 PRO LYS ASP GLY LEU LYS SER GLN ALA ALA PHE GLU GLU SEQRES 15 A 305 MET ARG THR ASN TYR ILE LYS GLU LEU ARG LYS MET VAL SEQRES 16 A 305 THR LYS SER PRO ASN ASN SER GLY GLN SER TRP GLN ARG SEQRES 17 A 305 PHE TYR GLN LEU THR LYS LEU LEU ASP SER MET HIS ASP SEQRES 18 A 305 LEU VAL SER ASP LEU LEU GLU PHE CYS PHE TYR THR PHE SEQRES 19 A 305 ARG GLU SER HIS ALA LEU LYS VAL GLU PHE PRO ALA MET SEQRES 20 A 305 LEU VAL GLU ILE ILE SER ASP GLN LEU PRO LYS VAL GLU SEQRES 21 A 305 SER GLY ASN ALA LYS PRO LEU TYR PHE HIS ARG LYS GLY SEQRES 22 A 305 GLY SER LEU VAL PRO ARG GLY SER GLY GLY GLY SER GLY SEQRES 23 A 305 GLY SER GLY GLY PRO GLN ALA GLN GLN LYS SER LEU LEU SEQRES 24 A 305 GLN GLN LEU LEU THR GLU SEQRES 1 B 15 PRO GLN ALA GLN GLN LYS SER LEU LEU GLN GLN LEU LEU SEQRES 2 B 15 THR GLU HET MPD A1101 8 HET EY8 A1102 29 HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM EY8 [(3~{R})-7-FLUORANYL-4-[(3-OXIDANYLIDENE-4~{H}-1,4- HETNAM 2 EY8 BENZOXAZIN-6-YL)CARBONYL]-2,3-DIHYDRO-1,4-BENZOXAZIN- HETNAM 3 EY8 3-YL]METHANESULFONAMIDE FORMUL 3 MPD C6 H14 O2 FORMUL 4 EY8 C18 H16 F N3 O6 S FORMUL 5 HOH *186(H2 O) HELIX 1 AA1 SER A 737 ILE A 745 1 9 HELIX 2 AA2 THR A 761 VAL A 786 1 26 HELIX 3 AA3 GLY A 789 LEU A 793 5 5 HELIX 4 AA4 PRO A 794 ASN A 823 1 30 HELIX 5 AA5 ASN A 836 SER A 843 1 8 HELIX 6 AA6 MET A 845 GLN A 863 1 19 HELIX 7 AA7 THR A 865 LEU A 878 1 14 HELIX 8 AA8 SER A 888 THR A 908 1 21 HELIX 9 AA9 TRP A 918 GLU A 948 1 31 HELIX 10 AB1 PRO A 957 SER A 973 1 17 HELIX 11 AB2 SER B 1433 GLU B 1441 1 9 SHEET 1 AA1 2 LEU A 827 ALA A 830 0 SHEET 2 AA1 2 LEU A 833 PHE A 835 -1 O PHE A 835 N LEU A 827 SHEET 1 AA2 2 THR A 880 PRO A 882 0 SHEET 2 AA2 2 ALA A 976 PRO A 978 -1 O LYS A 977 N ILE A 881 SITE 1 AC1 7 GLU A 746 PRO A 747 VAL A 780 TRP A 783 SITE 2 AC1 7 ALA A 813 LYS A 873 HOH A1261 SITE 1 AC2 16 ASN A 770 LEU A 772 ALA A 773 GLN A 776 SITE 2 AC2 16 MET A 807 SER A 810 SER A 811 LEU A 814 SITE 3 AC2 16 ARG A 817 PHE A 829 MET A 845 CYS A 849 SITE 4 AC2 16 PHE A 941 CYS A 942 THR A 945 VAL A 954 CRYST1 48.654 77.953 78.755 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020553 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012828 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012698 0.00000